DIAJARD FORTE XR 12.5/2.5/1000MG TAB

DIAJARD FORTE XR is a triple-action combination tablet designed for comprehensive diabetes management. Each tablet contains Empagliflozin 12.5mg, Linagliptin 2.5mg, and Metformin HCl 1000mg—three potent antidiabetic agents working synergistically to help regulate blood glucose levels. Empagliflozin works by promoting glucose excretion through urine, while Linagliptin enhances insulin secretion and reduces glucagon levels. Metformin improves insulin sensitivity and decreases hepatic glucose production. This combination approach addresses multiple pathways of hyperglycemia, making it suitable for patients requiring intensive glycemic control. DIAJARD FORTE XR's extended-release formulation ensures sustained medication delivery throughout the day, improving compliance and providing consistent blood sugar management. Ideal for Type 2 diabetes patients who need multi-mechanism therapy for optimal metabolic control. Always use as directed by your healthcare provider. Store in a cool, dry place away from moisture and direct sunlight.